Rebuilding the atrophied brain: 6-month nasal esketamine therapy expands key frontal and hippocampal regions and reduces serum neurofilament levels in patients with major depressive disorder. A proof-of-concept study of the depTesk (DEPression treatment with ESKetamine) study
Open Access
- 21 October 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 30 (1) , 1-29
Abstract
Objectives: This proof-of-concept study aimed to assess the impact of intranasal esketamine (ESK-IN) in brain volume and neurofilament light chain (sNfL) over 6-months in patients with treatment resistant depression (TDR). Methods: Seven TRD patients received ESK-IN while continuing oral antidepressants. Clinical evaluations were conducted at baseline, 1, 3, and 6 months, with MRI scans and blood samples taken at baseline and 6 months. Brain volume was assessed using VolBrain2 and DSI studio. Results: Compared to controls, TRD patients initially showed lower volumes (mm 3 ) in key cortical regions such as the insula (p = 0.0156), the frontal lobe (p = 0.0228) the superior parietal lobe (p = 0.0402), both superior (p = 0.0216) and inferior (p = 0.0437) temporal lobes and subcortical regions such as the nucleus accumbens (p = 0.0056), putamen (p = 0.0083), thalamus (p = 0.0102) and the hippocampus (p = 0.0001). Brain volume increased in the frontal cortex (p = 0.0295), the anterior cingulate (p = 0.0496), and hippocampus (p = 0.0015), as well as in the volume and fiber tracts associated with emotional regulation, such as the frontoparahippocampal (p = 0.0156 and p = 0.0313, respectively), the frontoparietal (p = 0.0496 and p = 0.0156, respectively) and the frontal aslant tract after 6 months on treatment with ESK-IN. In parallel, sNfL levels decreased post-treatment, indicating potential neuroprotective effects. Conclusions: ESK-IN may promote structural changes in regions associated with mood regulation and neuroplasticity, while also reducing neuronal damage in TRD patients.Keywords
This publication has 53 references indexed in Scilit:
- Prefrontal–hippocampal interactions in episodic memoryNature Reviews Neuroscience, 2017
- The role of myelination in measures of white matter integrity: Combination of diffusion tensor imaging and two-photon microscopy of CLARITY intact brainsNeuroImage, 2017
- Ketamine Mechanism of Action: Separating the Wheat from the ChaffNeuropsychopharmacology, 2016
- NMDAR inhibition-independent antidepressant actions of ketamine metabolitesNature, 2016
- A Diffusion Tensor Imaging Study Using a Voxel-Based Analysis, Region-of-Interest Method to Analyze White Matter Abnormalities in First-Episode, Treatment-Naïve Major Depressive DisorderThe Journal of Neuropsychiatry and Clinical Neurosciences, 2016
- Computational meta‐analysis of statistical parametric maps in major depressionHuman Brain Mapping, 2016
- Mapping immune cell infiltration using restricted diffusion MRIMagnetic Resonance in Medicine, 2016
- Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDDJournal of Psychiatry and Neuroscience, 2013
- Large-scale brain networks and psychopathology: a unifying triple network modelTrends in Cognitive Sciences, 2011
- White matter integrity deficit in treatment-naïve adult patients with major depressive disorder.2011